Global Drugs for Non-small Cell Lung Cancer Market Data Survey Report 2025
- HEY2866630
- 109 Pages
- January 2018
- Medical Devices
The global Drugs for Non-small Cell Lung Cancer market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Sanofi
Ziopharm Oncology
Alchemia
Alchemia
Apotex
BioMarin Pharmaceutical
CellAct Pharma
Cerulean Pharma
Cipla
Cornerstone Pharmaceuticals
Curis
CytRx
Eli Lilly
Exelixis
Fresenius Kabi
Genentech
Hikma Pharmaceuticals
Hospira
Intas Pharmaceuticals
Karyopharm Therapeutics
Kyowa Hakko Kirin
Ligand Pharmaceuticals
Major applications as follows:
Hospital
Clinic
Others
Major Type as follows:
Radiofrequency Ablation (RFA)
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Bristol-Myers Squibb
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 GlaxoSmithKline
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Menarini
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sanofi
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Ziopharm Oncology
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Alchemia
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Alchemia
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Apotex
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 BioMarin Pharmaceutical
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 CellAct Pharma
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Cerulean Pharma
3.12 Cipla
3.13 Cornerstone Pharmaceuticals
3.14 Curis
3.15 CytRx
3.16 Eli Lilly
3.17 Exelixis
3.18 Fresenius Kabi
3.19 Genentech
3.20 Hikma Pharmaceuticals
3.21 Hospira
3.22 Intas Pharmaceuticals
3.23 Karyopharm Therapeutics
3.24 Kyowa Hakko Kirin
3.25 Ligand Pharmaceuticals
4 Major Application
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Clinic
4.2.1 Overview
4.2.2 Clinic Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market by Type
5.1 Radiofrequency Ablation (RFA)
5.1.1 Overview
5.1.2 Radiofrequency Ablation (RFA) Market Size and Forecast
5.2 Radiation Therapy
5.2.1 Overview
5.2.2 Radiation Therapy Market Size and Forecast
5.3 Chemotherapy
5.3.1 Overview
5.3.2 Chemotherapy Market Size and Forecast
5.4 Targeted Therapies
5.4.1 Overview
5.4.2 Targeted Therapies Market Size and Forecast
5.5 Immunotherapy
5.5.1 Overview
5.5.2 Immunotherapy Market Size and Forecast
5.6 Immunotherapy
5.6.1 Overview
5.6.2 Immunotherapy Market Size and Forecast
6 Conclusion
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Volume, Price, Cost and Margin of Menarini
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Ziopharm Oncology
Tab Sales Revenue, Volume, Price, Cost and Margin of Alchemia
Tab Sales Revenue, Volume, Price, Cost and Margin of Alchemia
Tab Sales Revenue, Volume, Price, Cost and Margin of Apotex
Tab Sales Revenue, Volume, Price, Cost and Margin of BioMarin Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of CellAct Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Cerulean Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Cipla
Tab Sales Revenue, Volume, Price, Cost and Margin of Cornerstone Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Curis
Tab Sales Revenue, Volume, Price, Cost and Margin of CytRx
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Tab Sales Revenue, Volume, Price, Cost and Margin of Exelixis
Tab Sales Revenue, Volume, Price, Cost and Margin of Fresenius Kabi
Tab Sales Revenue, Volume, Price, Cost and Margin of Genentech
Tab Sales Revenue, Volume, Price, Cost and Margin of Hikma Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Hospira
Tab Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Karyopharm Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Kyowa Hakko Kirin
Tab Sales Revenue, Volume, Price, Cost and Margin of Ligand Pharmaceuticals
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
